Skip to main content

Table 4 Prevalence of abnormal imaging and biomarker results according to diabetes duration

From: Association of biomarkers and risk scores with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus

Quartile; Diabetes duration (y)

n

NTpBNP 125 pg/mL n (%)

GLS ≥ -16% n (%)

E/e’ ≥ 14 n (%)

e’ < 8 cm/s n (%)

LAVi > 34 ml/m2 n (%)

LVMi > 88 g/m2 (F), > 102 g/m2 (M) n (%)

 < 6

206

28 (13)

36 (18)

23 (11)

143 (67)

94 (44)

32 (15)

7–10

164

26 (15)

25 (16)

18 (11)

117 (68)

70 (41)

26 (15)

11–16

177

27 (15)

24 (14)

29 (16)

127 (70)

75 (41)

19 (10)

 > 16

175

39 (21)

36 (20)

45 (23)

143 (73)

102 (52)

30 (15)

p value

 

0.194

0.494

0.001

0.543

0.095

0.473

  1. GLS global longitudinal strain, LAVi left atrial volume indexed to body surface area, LVMi left ventricular mass indexed to body surface area
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840